X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs PLETHICO PHARMA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH PLETHICO PHARMA STERLING BIOTECH/
PLETHICO PHARMA
 
P/E (TTM) x -1.8 -1.1 - View Chart
P/BV x 0.1 0.0 422.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   PLETHICO PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
PLETHICO PHARMA
Mar-14
STERLING BIOTECH/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs11395 2.7%   
Low Rs331 10.9%   
Sales per share (Unadj.) Rs26.8604.4 4.4%  
Earnings per share (Unadj.) Rs-15.032.5 -46.1%  
Cash flow per share (Unadj.) Rs-5.551.3 -10.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9473.6 11.6%  
Shares outstanding (eoy) m267.8734.08 786.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.4 73.5%   
Avg P/E ratio x-0.56.6 -7.1%  
P/CF ratio (eoy) x-1.34.2 -30.6%  
Price / Book Value ratio x0.10.5 28.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8627,262 25.6%   
No. of employees `0001.4NA-   
Total wages/salary Rs m5471,596 34.3%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,18120,598 34.9%  
Other income Rs m43386 11.0%   
Total revenues Rs m7,22320,984 34.4%   
Gross profit Rs m9472,818 33.6%  
Depreciation Rs m2,543642 396.0%   
Interest Rs m4,3771,593 274.7%   
Profit before tax Rs m-5,931969 -612.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924-138 1,390.6%   
Profit after tax Rs m-4,0071,107 -362.0%  
Gross profit margin %13.213.7 96.4%  
Effective tax rate %32.4-14.3 -227.1%   
Net profit margin %-55.85.4 -1,038.3%  
BALANCE SHEET DATA
Current assets Rs m14,33518,877 75.9%   
Current liabilities Rs m49,80911,896 418.7%   
Net working cap to sales %-494.033.9 -1,457.8%  
Current ratio x0.31.6 18.1%  
Inventory Days Days40336 1,122.5%  
Debtors Days Days171198 86.3%  
Net fixed assets Rs m55,4329,861 562.2%   
Share capital Rs m268341 78.6%   
"Free" reserves Rs m13,93512,331 113.0%   
Net worth Rs m14,70116,139 91.1%   
Long term debt Rs m9,4784,706 201.4%   
Total assets Rs m73,98833,146 223.2%  
Interest coverage x-0.41.6 -22.1%   
Debt to equity ratio x0.60.3 221.1%  
Sales to assets ratio x0.10.6 15.6%   
Return on assets %0.58.1 6.1%  
Return on equity %-27.36.9 -397.4%  
Return on capital %-6.412.3 -52.3%  
Exports to sales %25.921.4 121.2%   
Imports to sales %0.215.2 1.1%   
Exports (fob) Rs m1,8604,402 42.2%   
Imports (cif) Rs m123,136 0.4%   
Fx inflow Rs m1,8604,402 42.2%   
Fx outflow Rs m253,184 0.8%   
Net fx Rs m1,8351,219 150.6%   
CASH FLOW
From Operations Rs m1,7192,437 70.5%  
From Investments Rs m-3,148-6,265 50.3%  
From Financial Activity Rs m1,4262,490 57.3%  
Net Cashflow Rs m-3-1,337 0.3%  

Share Holding

Indian Promoters % 33.9 82.7 41.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.3 -  
FIIs % 9.9 5.5 180.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 7.5 524.0%  
Shareholders   21,482 10,665 201.4%  
Pledged promoter(s) holding % 55.9 85.7 65.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   BIOCON LTD  CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  GLENMARK PHARMA  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 21, 2017 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS